Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

DNA methylation changes between relapse and remission of minimal change nephrotic syndrome.

Kobayashi Y, Aizawa A, Takizawa T, Yoshizawa C, Horiguchi H, Ikeuchi Y, Kakegawa S, Watanabe T, Maruyama K, Morikawa A, Hatada I, Arakawa H.

Pediatr Nephrol. 2012 Dec;27(12):2233-41. doi: 10.1007/s00467-012-2248-z. Epub 2012 Aug 2.

2.

Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome.

Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciuté A, Remy P, Loirat C, Niaudet P, Bensman A, Guellaen G.

J Am Soc Nephrol. 2001 Aug;12(8):1648-58.

3.

Genome-wide analysis of histone H3 lysine 4 trimethylation in peripheral blood mononuclear cells of minimal change nephrotic syndrome patients.

Zhang L, Dai Y, Peng W, Lu J, Zhang Y, Wang L.

Am J Nephrol. 2009;30(6):505-13. doi: 10.1159/000243811. Epub 2009 Oct 1.

4.

Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.

Okuyama S, Komatsuda A, Wakui H, Aiba N, Fujishima N, Iwamoto K, Ohtani H, Sawada K.

Nephrol Dial Transplant. 2005 Mar;20(3):539-44. Epub 2005 Jan 25.

PMID:
15671071
5.

Polymorphisms of interleukin-4--related genes in Japanese children with minimal change nephrotic syndrome.

Kobayashi Y, Arakawa H, Suzuki M, Takizawa T, Tokuyama K, Morikawa A.

Am J Kidney Dis. 2003 Aug;42(2):271-6.

PMID:
12900808
6.

Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome by cDNA microarrays.

Komatsuda A, Wakui H, Iwamoto K, Harada M, Okumoto Y, Sawada K.

Am J Nephrol. 2008;28(4):539-47. doi: 10.1159/000114098. Epub 2008 Jan 25.

PMID:
18219197
7.

Changes in DNA methylation in naïve T helper cells regulate the pathophysiological state in minimal-change nephrotic syndrome.

Kobayashi Y, Aizawa A, Takizawa T, Igarashi K, Hatada I, Arakawa H.

BMC Res Notes. 2017 Sep 15;10(1):480. doi: 10.1186/s13104-017-2719-1.

8.

A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening.

Sahali D, Pawlak A, Valanciuté A, Grimbert P, Lang P, Remy P, Bensman A, Guellaën G.

J Am Soc Nephrol. 2002 May;13(5):1238-47.

9.

NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome.

Valanciuté A, le Gouvello S, Solhonne B, Pawlak A, Grimbert P, Lyonnet L, Hue S, Lang P, Remy P, Salomon R, Bensman A, Guellaën G, Sahali D.

J Immunol. 2004 Jan 1;172(1):688-98.

10.

GATA-3 is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome.

Komatsuda A, Wakui H, Iwamoto K, Togashi M, Masai R, Maki N, Sawada K.

Clin Nephrol. 2009 Jun;71(6):608-16.

PMID:
19473628
11.

Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood.

González E, Neuhaus T, Kemper MJ, Girardin E.

Nephrol Dial Transplant. 2009 Jan;24(1):149-55. doi: 10.1093/ndt/gfn459. Epub 2008 Aug 12.

PMID:
18697798
12.

Abnormal RNA processing and altered expression of serin-rich proteins in minimal-change nephrotic syndrome.

Grimbert P, Audard V, Valanciute A, Pawlak A, Lang P, Guellaën G, Sahali D.

Pediatr Res. 2005 Jan;57(1):133-7. Epub 2004 Nov 5.

PMID:
15531747
13.

Influence of the relapse and remission periods on hearing status in children with minimal change nephrotic syndrome.

Bayazit YA, Balat A, Pakir HI, Güler E, Kanlikama M.

Rev Laryngol Otol Rhinol (Bord). 2005;126(3):171-3.

PMID:
16366385
14.

Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse.

Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC.

J Am Soc Nephrol. 1999 Mar;10(3):529-37.

15.

Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome.

Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE.

Pediatr Nephrol. 1999 Apr;13(3):199-204.

PMID:
10353405
16.

Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease.

Wei CL, Cheung W, Heng CK, Arty N, Chong SS, Lee BW, Puah KL, Yap HK.

Nephrol Dial Transplant. 2005 Apr;20(4):728-34. Epub 2005 Feb 22.

PMID:
15728267
17.

DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.

Agrawal S, Unterberg M, Koschmieder S, zur Stadt U, Brunnberg U, Verbeek W, Büchner T, Berdel WE, Serve H, Müller-Tidow C.

Cancer Res. 2007 Feb 1;67(3):1370-7.

18.

[Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].

Pruna A, Barka A, Nochy D, Hauet T, Boulanger H, Landais P.

Nephrologie. 1997;18(3):95-101. French.

PMID:
9297136
19.

T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome.

Topaloğlu R, Saatçi U, Arikan M, Canpinar H, Bakkaloğlu A, Kansu E.

Pediatr Nephrol. 1994 Dec;8(6):649-52.

PMID:
7696095
20.

Upregulation of nuclear factor-related kappa B suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome.

Audard V, Pawlak A, Candelier M, Lang P, Sahali D.

PLoS One. 2012;7(1):e30523. doi: 10.1371/journal.pone.0030523. Epub 2012 Jan 23.

Supplemental Content

Support Center